PMID: 1938222Jan 1, 1991

Effect of heparin and prostacyclin-heparin infusion on blood coagulation in haemodialysed patients

International Urology and Nephrology
M KuźniewskiJ Lisiewicz


In 10 patients (8 men and 2 women) aged 28 to 58 years (mean 44.4 years) treated by repeated haemodialysis due to end-stage renal failure, the bleeding time, whole-blood coagulation time, one-stage prothrombin time, thrombin time of plasma, activated partial thromboplastin time (APTT), fibrinogen level and euglobulin lysis time have been determined (1) during a 4-hour haemodialysis using heparin as an antithrombotic agent, and (2) one week later in the course of another haemodialysis using prostacyclin-heparin. The values for any of the above parameters with both anticoagulant treatment types did not differ. Plasma fibrinogen level after haemodialysis was significantly lower after administration of heparin alone as compared with the group treated by prostacyclin-heparin infusion. During haemodialysis performed with prostacyclin-heparin infusion, activation of the blood fibrinolytic system was manifested by a significant shortening of euglobulin lysis time, observed after 1.5 hours and after the end of haemodialysis. The above phenomenon did not occur when haemodialysis was performed with heparin alone.


Nov 18, 1978·Lancet·H F WoodsJ R Vane
Sep 15, 1979·Lancet·P GlaserB Eurin
Jan 16, 1975·The New England Journal of Medicine·R D Rosenberg
May 1, 1978·British Medical Bulletin·T W BarrowcliffeD Thomas
Aug 1, 1978·Thrombosis Research·R J GryglewskiR Nizankowski
Jan 1, 1979·Journal of Applied Behavior Analysis·A LakeJ D Papsdorf
Oct 1, 1979·Bulletin of Environmental Contamination and Toxicology·B R ParkhurstG P Wright
Jun 1, 1987·Kidney International·R J CaruanaS J Goldstein
May 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·S J Jubelirer
Mar 1, 1974·Thrombosis Research·R G LeeS W Kim
Dec 1, 1972·Journal of Clinical Pathology·E N Wardle, D A Piercy
Apr 1, 1974·Circulation·R D Rosenberg
Dec 8, 1971·Nature: New Biology·W W De Jong
Jul 1, 1970·Journal of Clinical Pathology·A A HassaneinA S Douglas
Apr 1, 1968·The Journal of Clinical Investigation·S F Rabiner, O Hrodek
Dec 12, 1981·Lancet·G RemuzziG de Gaetano
Jan 1, 1980·The Journal of Clinical Investigation·E W SalzmanL Favreau
Jan 6, 1983·The New England Journal of Medicine·P M MannucciT S Zimmerman
Jun 1, 1982·Pharmacological Research Communications·A Dembińska-KiećT Zelazny
Nov 1, 1982·The American Journal of Medicine·M C SmithM J Dunn
May 23, 1981·British Medical Journal·J H TurneyM J Weston
Feb 1, 1980·Prostaglandins·J O'GradyS Moncada
Apr 16, 1981·The New England Journal of Medicine·R M ZusmanN Tolkoff-Rubin
Feb 1, 1958·American Journal of Clinical Pathology·K N VON KAULLA, R L SCHULTZ
Jul 1, 1962·British Journal of Haematology·K CHENEY, J A BONNIN


Jan 1, 1992·International Urology and Nephrology·M Kuźniewski, W Sułowicz

Related Concepts

Blood Coagulation
Blood Coagulation Tests
Intravenous Infusion Procedures
Kidney Failure, Chronic

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.